Editorial

Immuno-Oncology Essentials: An Overview

Brianna Hoffner, MSN, ANP-BC, AOCNP®

University of Colorado Cancer Center—Anschutz, Aurora, Colorado

Author’s disclosures of conflicts of interest are found at the end of this article.

Brianna Hoffner, MSN, ANP-BC, AOCNP®, 1665 Aurora Court, Aurora, CO 80045. E-mail: brianna.hoffner@ucdenver.edu


J Adv Pract Oncol 2019;10(suppl 1):7–8 | https://doi.org/10.6004/jadpro.2019.10.2.9 | © 2019 Harborside™


  

ABSTRACT

This article is a part of a JADPRO certified supplement, Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events

Table of Contents

  1. Immuno-Oncology Essentials: An Overview (current article)
  2. Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
  3. PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
  4. Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
  5. Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
  6. Appendix: Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management




For access to the full length article, please sign in.

Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.